These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 26112187)

  • 21. [Evidence of HTLV-1 infection in different groups at risk in Barcelona].
    Soriano V; Tor J; Ribera A; Clotet B; Muga R; Pauplana M; Abellá E; Fernández JL; Flores A; Foz M
    Med Clin (Barc); 1990 Jan; 94(1):5-8. PubMed ID: 2335981
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural and epidemiological features of primate lymphotropic retroviruses.
    Hunsmann G; Schneider J; Bayer H; Jurkiewicz E; Yamamoto N
    Princess Takamatsu Symp; 1984; 15():109-18. PubMed ID: 6100632
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retroviruses and inflammatory myopathies in humans and primates.
    Dalakas MC
    Baillieres Clin Neurol; 1993 Nov; 2(3):659-91. PubMed ID: 8156147
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kaplan memorial lecture. The family of human lymphotropic retroviruses called HTLV: HTLV-I in adult T-cell leukemia (ATL), HTLV-II in hairy cell leukemias, and HTLV-III in AIDS.
    Gallo RC
    Princess Takamatsu Symp; 1984; 15():13-38. PubMed ID: 6100633
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Short communication: Prevalence and risk factors for human T cell lymphotropic virus infection in Southern Brazilian HIV-positive patients.
    Galetto LR; Lunge VR; Béria JU; Tietzmann DC; Stein AT; Simon D
    AIDS Res Hum Retroviruses; 2014 Sep; 30(9):907-11. PubMed ID: 24866083
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retroviruses associated with leukemia and ablative syndromes in animals and in human beings.
    Essex M; McLane MF; Kanki P; Allan J; Kitchen L; Lee TH
    Cancer Res; 1985 Sep; 45(9 Suppl):4534s-4538s. PubMed ID: 2990682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human T-lymphotropic virus 1 (HTLV-1) infection--dermatological implications.
    Amano M; Setoyama M; Grant A; Kerdel FA
    Int J Dermatol; 2011 Aug; 50(8):915-20. PubMed ID: 21781059
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sequence analysis of an immunogenic and neutralizing domain of the human T-cell lymphoma/leukemia virus type I gp46 surface membrane protein among various primate T-cell lymphoma/leukemia virus isolates including those from a patient with both HTLV-I-associated myelopathy and adult T-cell leukemia.
    Sherman MP; Dube S; Spicer TP; Kane TD; Love JL; Saksena NK; Iannone R; Gibbs CJ; Yanagihara R; Dube DK
    Cancer Res; 1993 Dec; 53(24):6067-73. PubMed ID: 8261424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HIV/human T-cell lymphotropic virus coinfection revisited: impact on AIDS progression.
    Brites C; Sampalo J; Oliveira A
    AIDS Rev; 2009; 11(1):8-16. PubMed ID: 19290030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative seroepidemiology of HTLV-I and HTLV-III in the French West Indies and some African countries.
    de-Thé G; Gessain A; Gazzolo L; Robert-Guroff M; Najberg G; Calender A; Peti M; Brubaker G; Bensliman A; Fabry F
    Cancer Res; 1985 Sep; 45(9 Suppl):4633s-4636s. PubMed ID: 2990698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic aspects of retroviral disease.
    Peto T
    Baillieres Clin Neurol; 1992 Apr; 1(1):239-57. PubMed ID: 1344652
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HTLV: epidemiology and relationship to disease.
    Blattner WA; Clark JW; Gibbs WN; Williams CK; Nomura A; Mann D; Saxinger C; Robert-Guroff M; Gallo RC
    Princess Takamatsu Symp; 1984; 15():93-108. PubMed ID: 6100653
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Human retrovirus HTLV-1: descriptive and molecular epidemiology, origin, evolution, diagnosis and associated diseases].
    Gessain A
    Bull Soc Pathol Exot; 2011 Aug; 104(3):167-80. PubMed ID: 21796326
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Virus-associated lymphomas, leukaemias and immunodeficiencies in Africa.
    de-Thé G
    IARC Sci Publ; 1984; (63):727-44. PubMed ID: 6100286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inflammatory manifestations of HTLV-1 and their therapeutic options.
    Martin F; Taylor GP; Jacobson S
    Expert Rev Clin Immunol; 2014 Nov; 10(11):1531-46. PubMed ID: 25340428
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Virological aspects of HTLV-1 infection and new therapeutical concepts].
    Mahieux R
    Bull Soc Pathol Exot; 2011 Aug; 104(3):181-7. PubMed ID: 21607661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of resistance to rhabdovirus and retrovirus infection in a human myeloid cell line.
    Boso G; Somia NV
    PLoS One; 2015; 10(3):e0121455. PubMed ID: 25811758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A historical reflection on the discovery of human retroviruses.
    Vahlne A
    Retrovirology; 2009 May; 6():40. PubMed ID: 19409074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HTLV-I infection in the Free State region of South Africa: a sero-epidemiologic study.
    van der Ryst E; Joubert G; Smith MS; Terblanche M; Mollentze F; Pretorius AM
    Cent Afr J Med; 1996 Mar; 42(3):65-8. PubMed ID: 8653770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [HTLV-I infection in Spain. Analysis of 24 cases identified until November, 1994. Spanish Group for the Study of HTLV-I/II)].
    Soriano V; Gutiérrez M; Vallejo A; Aguilera A; Calderón E; Franco E
    Med Clin (Barc); 1995 Sep; 105(7):246-50. PubMed ID: 7475464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.